-+ 0.00%
-+ 0.00%
-+ 0.00%

GEOVAX ANNOUNCES POSITIVE INTERIM DATA REVIEW FOR PHASE 2 CLINICAL TRIAL OF COVID-19 VACCINE BOOSTER IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Reuters·11/19/2024 14:00:01

Please log in to view news